Literature DB >> 10460456

Plasmapheresis and immunosuppression in stiff-man syndrome with type 1 diabetes: a 2-year study.

W Hao, C Davis, I B Hirsch, L J Eng, T Daniels, D Walsh, A Lernmark.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10460456     DOI： 10.1007/s004150050443

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

Authors:  Esther Ganelin-Cohen; Dalit Modan-Moses; Rina Hemi; Hannah Kanety; Bruria Ben-Zeev; Christiane S Hampe
Journal:  Pediatr Diabetes       Date:  2015-12-29       Impact factor: 4.866

2.  Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases.

Authors:  Anil Tombak; Mehmet Ali Uçar; Aydan Akdeniz; Arda Yilmaz; Hakan Kaleagası; Mehmet Ali Sungur; Eyup Naci Tiftik
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-22       Impact factor: 0.900

3.  Conformation-dependent GAD65 autoantibodies in diabetes.

Authors:  D Luo; L K Gilliam; C Greenbaum; L Bekris; C S Hampe; T Daniels; W Richter; S M Marcovina; O Rolandsson; M Landin-Olsson; I Kockum; A Lernmark
Journal:  Diabetologia       Date:  2004-09-08       Impact factor: 10.122

4.  Stiff-person Syndrome.

Authors:  Olavo M. Vasconcelos; Marinos C. Dalakas
Journal:  Curr Treat Options Neurol       Date:  2003-01       Impact factor: 3.598

Review 5.  Neurological Syndromes Associated with Anti-GAD Antibodies.

Authors:  Maëlle Dade; Giulia Berzero; Cristina Izquierdo; Marine Giry; Marion Benazra; Jean-Yves Delattre; Dimitri Psimaras; Agusti Alentorn
Journal:  Int J Mol Sci       Date:  2020-05-24       Impact factor: 5.923

Review 6.  GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions.

Authors:  Popianna Tsiortou; Harry Alexopoulos; Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2021-03-30       Impact factor: 6.570

7.  Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.

Authors:  Franziska S Thaler; Luise Zimmermann; Stefan Kammermeier; Christine Strippel; Marius Ringelstein; Andrea Kraft; Kurt-Wolfram Sühs; Jonathan Wickel; Christian Geis; Robert Markewitz; Christian Urbanek; Claudia Sommer; Kathrin Doppler; Loana Penner; Jan Lewerenz; Rosa Rößling; Carsten Finke; Harald Prüss; Nico Melzer; Klaus-Peter Wandinger; Frank Leypoldt; Tania Kümpfel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-10-01

Review 8.  Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies.

Authors:  Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2022-01-27       Impact factor: 6.088

9.  Improving Ambulation and Minimizing Disability with Therapeutic Plasma Exchange in a Stiff-person Syndrome Patient with Recurrent Falls.

Authors:  Kyle Sanchez; Aqsa Ullah; Alexandria R Waler; Yassar Chakfe
Journal:  Cureus       Date:  2019-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.